E
ENVXAI Stock Diagnostic Report
Enovix expects Q3 revenue of $11M; shares jump 13%
Enovix shares surged 13% as the company presented a third-quarter sales forecast of $11 million.
View Source Article ↗AI CATALYST SCORE78 / 100Score computed by Sentinel V12
REFERENCE PRICE$2.46Reference entry price at analysis time
01
MARKET SNAPSHOT
Key Indicators at a Glance
Major Support2.40
Near-Term Resistance3.10
02
FUNDAMENTALS
Financial & Fundamental Analysis
Enovix's Q3 revenue guidance of $11M provides short-term performance visibility, but financial momentum is limited, making it insufficient to fundamentally reverse the recent 15.2% decline in the stock price over the past seven days.
03
TECHNICAL VIEW
Technical Position & Response Criteria
The current price of $2.46 is near the 20-day low ($2.40), placing it in a test zone for downside support; upon a rebound, the 20-day high of $3.10 will act as a major resistance level.
Support2.40
Resistance3.10
04
CATALYST & STRATEGY
Catalyst Analysis & Forward Strategy
Driven by the announcement of expected Q3 sales of $11M, the stock surged 13%, but the achievement of sustained earnings going forward remains the key condition for further upside.
05
PROOF OF WORK
Analysis Point vs. Subsequent Price Action
INITIAL · At Analysis (2026-10-12)
FINAL · Current/Verified
Renders the actual stored OHLC data directly in your browser.